Skip Navigation


JAC Advance Access originally published online on June 15, 2005
Journal of Antimicrobial Chemotherapy 2005 56(2):307-314; doi:10.1093/jac/dki200
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/2/307    most recent
dki200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brun, S.
Right arrow Articles by Bouchara, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brun, S.
Right arrow Articles by Bouchara, J.-P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Biological consequences of petite mutations in Candida glabrata

Sophie Brun1, Frédéric Dalle2, Patrick Saulnier3, Gilles Renier4, Alain Bonnin2, Dominique Chabasse1 and Jean-Philippe Bouchara1,*

1 Groupe d'Etude des Interactions Hôte-Parasite, UPRES-EA 3142, Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire, 4 rue Larrey, 49033 Angers Cedex, France; 2 Laboratoire de Parasitologie-Mycologie, Hôpital du Bocage, 21079 Dijon Cedex, France; 3 INSERM U 646, 10 rue André Boquel, 49100 Angers, France; 4 Laboratoire d'Immunologie, Centre Hospitalier Universitaire, 4 rue Larrey, 49033 Angers Cedex, France

Received 18 February 2005; returned 2 April 2005; revised 28 April 2005; accepted 20 May 2005


* Corresponding author. Tel: +33-02-41-35-34-72; Fax: +33-02-41-35-36-16; E-mail: jean-philippe.bouchara{at}univ-angers.fr

Objectives: To define the pathogenicity of respiration-deficient mutants of Candida glabrata, which present a reduced susceptibility to azoles, that are easily induced in vitro by exposure to these drugs or to ethidium bromide and that may be selected in vivo in patients receiving fluconazole.

Methods: Two wild-type isolates of C. glabrata were compared with their respective fluconazole- or ethidium bromide-induced petite mutants, regarding the carbohydrate and protein composition of the cell wall, as well as their surface physical properties, and also their adherence abilities and virulence in mice.

Results: Flow cytometric analysis of cell wall carbohydrates using several fluorescent lectins showed an increased binding of mutant cells to concanavalin A compared with their parent isolates, suggesting a greater availability or an increased amount of glucose–mannose residues at the cell surface in petite mutants. Likewise, some quantitative differences between parent and mutant isolates were shown by SDS–PAGE in protein extracts from blastoconidia. Regarding the surface physical properties, no significant differences were seen in the electrophoretic mobility determined by microelectrophoresis, but the two-phase partitioning method revealed a lower cell surface hydrophobicity for petite mutants. Moreover, mutant cells exhibited significant overexpression of CgEPA1 as revealed by real-time reverse transcription-PCR, but the adherence capacities to Caco-2 cells, a human enterocyte line, were not significantly different. Finally, in agreement with their slower growth, petite mutants were less virulent than parent isolates in a murine model of systemic infection.

Conclusion: This low virulence in mice suggests that petite mutants could be disregarded clinically although they may arise during fluconazole therapy.

Keywords: petite mutants , cell surface hydrophobicity , adherence , virulence


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
B. Posteraro, R. Martucci, M. La Sorda, B. Fiori, D. Sanglard, E. De Carolis, A. R. Florio, G. Fadda, and M. Sanguinetti
Reliability of the Vitek 2 Yeast Susceptibility Test for Detection of In Vitro Resistance to Fluconazole and Voriconazole in Clinical Isolates of Candida albicans and Candida glabrata
J. Clin. Microbiol., June 1, 2009; 47(6): 1927 - 1930.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
K. Gulshan and W. S. Moye-Rowley
Multidrug Resistance in Fungi
Eukaryot. Cell, November 1, 2007; 6(11): 1933 - 1942.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Cheng, C. J. Clancy, K. T. Nguyen, W. Clapp, and M. H. Nguyen
A Candida albicans Petite Mutant Strain with Uncoupled Oxidative Phosphorylation Overexpresses MDR1 and Has Diminished Susceptibility to Fluconazole and Voriconazole
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1855 - 1858.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.